Table 2.
Hemodynamic characteristics of pairs of CFI/LVEF measurements (n = 72).
| Mean | SD | ||
|---|---|---|---|
| Patient data | |||
| Norepinephrine (μg/kg/min) | 0.72 | ±0.79 | n = 38 |
| Epinephrine (μg/kg/min) | 0.77 | — | n = 1 |
| Dobutamine (μg/kg/min) | 9.4 | ±4.8 | n = 63 |
| Systolic arterial pressure (mmHg) | 121 | ±20 | n = 72 |
| Diastolic arterial pressure (mmHg) | 60 | ±12 | n = 72 |
| Mean arterial pressure (mmHg) | 80 | ±15 | n = 72 |
| Heart rate (/min) | 100 | ±19 | n = 72 |
| Echocardiography data | |||
| Left ventricular ejection fraction (%) | 31% | ±11.7 | n = 72 |
| Pulmonary systolic arterial pressure (mmHg) | 44 | ±12.3 | n = 38 |
| TAPSE (mm) | 18.4 | ±4.7 | n = 63 |
| Transpulmonary thermodilution data | |||
| Cardiac index (L/min/m2) | 2.6 | ±0.8 | n = 72 |
| Cardiac function index (/min) | 3 | ±1 | n = 72 |
| Global ejection fraction (%) | 14.2 | ±6 | n = 72 |
| Global end diastolic volume (mL/m2) | 820 | ±190 | n = 72 |
CFI: cardiac function index; LVEF: left ventricular ejection function; TAPSE: tricuspid annular plane systolic excursion.